Navigation Links
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2009 Results; Teleconference and Webcast to be held on September 8, 2009
Date:9/8/2009

pressure was seen in subjects receiving bremelanotide compared to placebo.
  • Scheduled a meeting with the Food and Drug Administration to discuss initiation of a Phase 2B clinical trial of subcutaneously administered bremelanotide in erectile dysfunction patients non-responsive to phosphodiesterase-5 inhibitors, the current standard therapy for erectile dysfunction.
  • Reported on two human clinical trials of PL-3994, Palatin's drug under development for the treatment of heart failure. A Phase 1 study in healthy volunteers was presented at the Heart Failure Society of America Meeting in Toronto in September 2008 and a Phase 2A study in patients with controlled hypertension will be presented at the September 2009 Heart Failure Society of America Meeting.
  • Conducted a proof-of-principle clinical study on the effects of a melanocortin receptor-specific compound on food intake, obesity and other metabolic parameters pursuant to a clinical trial sponsored research agreement with AstraZeneca.

    • Amended and extended agreements with AstraZeneca, including entering into a clinical trial sponsored research agreement. In addition to reimbursement of Palatin's activities at an agreed full-time equivalent rate, during the fiscal year ended June 30, 2009 Palatin received payments of $6.6 million from AstraZeneca, $5.7 million of which was recognized as revenue during the fiscal year.

    • Raised approximately $2.8 million in net proceeds of a registered direct offering, after deducting placement agent fees and other offering expenses, in August 2009, subsequent to fiscal year end.

    REVENUE

    For the quarter ended June 30, 2009, Palatin recognized $4.2 million of revenue under its agreements with AstraZeneca. In the comparable quarter of 2008, Palatin recognized $0.8 mill
    '/>"/>

    SOURCE Palatin Technologies, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7

    Related biology technology :

    1. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
    2. Palatin Technologies Refutes Competitive Technologies Contention of Material Breach
    3. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
    4. Palatin Technologies to Report Fiscal Year 2008 First Quarter Results; Teleconference and Webcast on November 9, 2007
    5. Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007
    6. Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th
    7. Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
    8. Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th
    9. Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
    10. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
    11. Palatin Technologies, Inc. Revised Call-In Number for Teleconference and Webcast to be held on September 30, 2008

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/19/2009)...swire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS... letter to its shareholders, discussing the Compan...pharmaceuticals Holdings, Inc. (CHBP), an integrat...s Republic of China. The merger gives NeoStem a co...al Co. Ltd., CHBP,s primary operating subsidiary a...
    (Date:11/19/2009)... surgeons and recognized refractive and cataract s...de brought their fellow surgeons up-to-date on the... cataract surgery, and ophthalmology in general at...lmology (AAO) annual meeting in San Francisco, Cal..., Dr. David Huang, MD, Dr. Randy Epstein, Dr. Will...
    (Date:11/18/2009)...te of Standards and Technology (NIST) has demonstr...etecting and measuring elusive hazards such as con...n food or pesticides distributed in soil by wind a...an conventional techniques for detecting traces of...les, having distinct electrically positive and neg...
    (Date:11/18/2009)...in data analysis combined with Bio-Rad,s Biote...rricula provide state-of-the-art solutions to biot...18 Vernier Software & Technolo...sensors, and software and Bio-Rad Laboratories, In...f life science research and clinical diagnostics p...
    Breaking Biology Technology:NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9Prototype NIST method detects and measures elusive hazards 2Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2
    ... Award for significant boost to ...io,s ability to attract,multi-million dollar busin...ea Development magazine, which awarded the state w...l is awarded to states that have generated,top job...highly active in,business development initiatives....
    ...Control, the Houston based pest control and animal...t Quality Pro designation, a mark of excellence in...tion, awarded by the National Pest Management Asso...nced Pest Control has taken to ensure their custom...ton, TX (PRWEB) September 9, 2008 -- Advanced Pest...
    ...m Dartmouth,s Thayer School of Engineering and Mas...covery that is important for producing large quant...or a sustainable and secure alternative to petrole..., the group has genetically engineered a thermophi...emperatures, and this new microorganism makes etha...
    Other Biology Technology:Ohio Recognized as National Leader for Business Development and Job Creation 2Ohio Recognized as National Leader for Business Development and Job Creation 3Advanced Pest Control Earns Quality Pro Designation for General Pest Control Services 2Advanced Pest Control Earns Quality Pro Designation for General Pest Control Services 3Dartmouth researchers advance cellulosic ethanol production 2
    (Date:11/20/2009)... - Bacteria possess an ingenious mechanism for pre... the cell. This is the new finding of a team of bi...e sciences research institute in Flanders, Belgium... scientists made this discovery by modifying the D... By means of this model organism, they have uncove...
    (Date:11/20/2009)...ry disease (COPD), a respiratory disease commonly ...ourth leading cause of death worldwide. 600 milli...e yet to find any real treatment or cure, Grace Pa...ity of Western Ontario in London, Canada, is using...to the disease. , Parraga is a scientist in ...
    (Date:11/19/2009)...brain chemical with an unwieldy name: 4-hydroxybut...used as a date-rape drug. , Now, a team of Ohio...s by which 4-HB is metabolized by the body. "This ... Gibson, professor and chair of biological science...r of the research team. "It may provide new clues...
    Breaking Biology News(10 mins):Biologists discover bacterial defense mechanism against aggressive oxygen 2Gaining a better picture of lung disease 2Researchers begin to decipher metabolism of sexual assault drug 2Celsis Outlines the Top Five Advantages of Cryo plateable Hepatocytes 12642 1Celsis Outlines the Top Five Advantages of Cryo plateable Hepatocytes 12642 2Celsis Outlines the Top Five Advantages of Cryo plateable Hepatocytes 12642 3Celsis Outlines the Top Five Advantages of Cryo plateable Hepatocytes 12642 4Sinus Infections Can Cause Toxic Shock in Kids 49007 1Sinus Infections Can Cause Toxic Shock in Kids 49007 2Test detects molecular marker of aging in humans 8849 1Test detects molecular marker of aging in humans 8849 2
    ...2009) -- Rice University materials scientists have...researchers found the highly touted nanomaterials ...isting, single-atom threads. , Carbon nanotubes a...one nanometer, or one-billionth of a meter, in dia...d-up sheets of chicken wire. And just like a roll ...
    ... place or taking part in protein folding to ensure...l. Simulating molecular motions provides researche... and helps them decipher the bases of certain dise...sult from molecular motion gone awry. , In the pas...ge computer clusters to run simulations. Or they h...
    ...nologies announces the availability of its complet...as Instruments TMS320C64x+(TM) high performance DS...gital Technologies (Adaptive Digital), a leading p...l signal processing (DSP) software solutions and v... the availability of its complete suite of applica...
    Other Biology News:Nanotube's 'tapestry' controls its growth 2New open-source software permits faster desktop computer simulations of molecular motion 2New open-source software permits faster desktop computer simulations of molecular motion 3High Performance, Low-Cost VoIP Chips Address Critical Performance Issues Such as Echo, Latency, and Packet Loss 2High Performance, Low-Cost VoIP Chips Address Critical Performance Issues Such as Echo, Latency, and Packet Loss 3
    Thermo Scientific Sorvall RC12BP low speed centrifuge from Thermo Scientific
    ...Moloney Murine Leukemia Virus Reverse Transcriptas...at can be used in cDNA synthesis with long messeng...f the pol gene of M-MLV and consists of a single s... H activity of M-MLV RT is weaker than the commonl...
    ...DNase I, ds Qualified is a special preparation of ...ble stranded cleavage of DNA molecules. In the pre...s double strand breaks at random sites in DNA. The...ntrolled by the enzyme concentration and incubatio...
    Synthetic Peptide Synthesis from rPeptide, LLC
    Biology Products: